Everolimus Added to Adjuvant Endocrine Therapy in Patients With High-Risk Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Primary Breast Cancer

Bibliographic Details
Title: Everolimus Added to Adjuvant Endocrine Therapy in Patients With High-Risk Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Primary Breast Cancer
Authors: Bachelot, Thomas, Cottu, Paul, Chabaud, Sylvie, Dalenc, Florence, Allouache, Djelila, Delaloge, Suzette, Jacquin, Jean-Philippe, Grenier, Julien, Venat Bouvet, Laurence, Jegannathen, Apurna, Campone, Mario, Del Piano, Francesco, Debled, Marc, Hardy-Bessard, Anne-Claire, Giacchetti, Sylvie, Mouret-Reynier, Marie-Ange, Barthelemy, Philippe, Kaluzinski, Laure, Mailliez, Audrey, Legouffe, Eric, Sephton, Matthew, Bliss, Judith, Canon, Jean-Luc, Penault-Llorca, Frederique, Lemonnier, Jerome, Cameron, David, Andre, Fabrice
Source: Journal of clinical oncology. 40(32):3699-3708
Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100173048253.0x000001&indx=1&recIds=ETOCvdc_100173048253.0x000001
Database: British Library Document Supply Centre Inside Serials & Conference Proceedings
More Details
ISSN:0732183X
Published in:Journal of clinical oncology
Language:English